Combination of CO2 laser therapy and pulsed dye laser therapy for the treatment of actinic cheilitis

Carolina Donelli,E. Trovato,P. Rubegni,Ivana Guidi,G. Cortonesi,C. Orsini

DOI: https://doi.org/10.1111/jocd.15494

2022-11-16

Journal of Cosmetic Dermatology

Abstract:To the Editor, Actinic cheilitis (AC) is a premalignant condition affecting the mucosal epithelium of the lip, generally related to the chronic exposure to UV solar irradiation.1 Clinical manifestations of AC include dryness, atrophy, scaling, erythema, ulceration, and poorly demarcated borders.2,3 It may progress to squamous cell carcinoma (SCC) of the lip, which has a metastasis rate four times higher than a peripheral cutaneous SCC,4,5 so early diagnosis is a challenge for dermatologists. The treatment of AC is directed to destruction of the damaged epithelium, promoting normal reepithelization of the lip. Various surgical and nonsurgical methods such as chemical peeling with trichloroacetic acid, topical tretinoin, 5fluorouracil, diclofenac, imiquimod, cryosurgery, electrocautery, dermabrasion, carbon dioxide (CO2) laser, Er:YAG laser, scalpel vermilionectomy, and photodynamic therapy (PDT) have been used.2 Based on recent studies, surgicalassisted laser therapy seems to outperform the other therapeutic options highlighting high rates of complete response, and low recurrence rates. In addition, most studies underline relevant cosmetic outcomes and excellent patient satisfaction. However, sequential employment of two different therapies seems to act synergically on reaching the final therapeutic outcome. To date, in literature there are only studies that use association of PDT and CO2 laser therapy for the treatment of these conditions. 3,5 We report the case of two male patients, respectively, aged 73 (patient 1) and 79 (patient 2), presented to our hospital for persistent scaly erythematousulcerated plaque of the lower lip (Figure 1A,B) which clinically and dermoscopically suggested the diagnosis of actinic cheilitis. One of them referred to had relapsed after being treated at another center with CO2 laser only. We performed punch biopsy in both patients, in order to rule out the presence of a SCC, confirming our diagnostic hypothesis. First, under local anesthesia, the patients underwent a CO2 laser (Smartxide, 2 DEKA MELA, Florence) ablative treatment (power 0.5– 1.5 W, frequency 20 Hz) (Figure 1C) and, immediately after we performed Flashlamp PulsedDye Laser (FPDL) (Synchro VasQ, DEKA MELA, Florence) using a 7mm spot size, 1.5 ms pulse duration, and energy fluence of 8 J/cm2. After therapy, they were advised to apply until complete reepithelization (from 5– 10 days) a topical nonmedicated ointment containing panthenol and glycerin on the treated area, in order to avoid excessive dryness of the zone and to promote a quickly healing. We did again only FPDL after 3 and 5 weeks. Patients were warned to avoid sun and cosmetics in the 4 weeks immediately after lasers. A followup was performed after 6 and 12 months (Figure 1D,E) to evaluate the efficacy of the combined treatment. We suggested patients to undergo a second biopsy in order to demonstrate the histological healing of the lesions, but both patients refused because there was no clinical

Medicine